Trials / Completed
CompletedNCT02862223
A Study Investigating the Effects of Neprinol Study Product on Vascular Function
Neprinol for Cardiovascular Health
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This open-label study investigated the effectiveness of Neprinol on maintaining healthy cardiovascular health in overweight and obese adults. Subjects took 3 capsules, 3 times per day over a period of 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Neoprinol |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-03-01
- First posted
- 2016-08-10
- Last updated
- 2017-01-09
Source: ClinicalTrials.gov record NCT02862223. Inclusion in this directory is not an endorsement.